DHC - Diversified Healthcare Trust Stock Price, Fair Value and News

2.41USD-0.02 (-0.82%)Market Closed

Market Summary

USD2.41-0.02

Market Closed

-0.82%

DHC Stock Price

View Fullscreen

DHC RSI Chart

DHC Valuation

Market Cap

579.4M

Price/Earnings (Trailing)

-1.97

Price/Sales (Trailing)

0.41

EV/EBITDA

1.64

Price/Free Cashflow

55.27

DHC Price/Sales (Trailing)

DHC Profitability

EBT Margin

-19.33%

Return on Equity

-12.56%

Return on Assets

-5.39%

Free Cashflow Yield

1.81%

DHC Fundamentals

DHC Revenue

Revenue (TTM)

1.4B

Rev. Growth (Yr)

7.32%

Rev. Growth (Qtr)

1.41%

DHC Earnings

Earnings (TTM)

-293.6M

Earnings Growth (Yr)

-57.01%

Earnings Growth (Qtr)

-55.92%

Breaking Down DHC Revenue

Last 7 days

2.1%

Last 30 days

-7.0%

Last 90 days

-15.4%

Trailing 12 Months

155.4%

How does DHC drawdown profile look like?

DHC Financial Health

DHC Investor Care

Shares Dilution (1Y)

0.31%

Diluted EPS (TTM)

-1.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.3B	1.4B	1.4B	1.4B
2022	1.3B	1.3B	1.3B	1.3B
2021	1.6B	1.5B	1.4B	1.4B
2020	1.2B	1.4B	1.5B	1.6B
2019	1.1B	1.1B	1.1B	1.0B
2018	1.1B	1.1B	1.1B	1.1B
2017	1.1B	1.1B	1.1B	1.1B
2016	1.0B	1.0B	1.1B	1.1B
2015	882.0M	922.7M	961.1M	998.8M
2014	766.0M	785.8M	815.4M	844.9M
2013	679.1M	721.6M	752.8M	761.4M
2012	494.1M	537.3M	579.7M	634.8M
2011	358.2M	378.6M	411.4M	450.0M
2010	308.8M	320.2M	329.2M	340.1M
2009	0	254.4M	275.6M	296.8M
2008	0	0	0	233.2M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Diversified Healthcare Trust

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jun 14, 2023	portnoy adam d.	bought	6,132,600	3.0663	2,000,000	-
Jun 13, 2023	portnoy adam d.	bought	6,026,780	3.0251	1,992,260	-
Jun 12, 2023	portnoy adam d.	bought	5,778,540	2.8731	2,011,260	-
Jun 09, 2023	portnoy adam d.	bought	4,943,230	2.5946	1,905,200	-
Jun 08, 2023	portnoy adam d.	bought	4,163,820	2.4638	1,690,000	-
Jun 07, 2023	portnoy adam d.	bought	5,609,520	2.3373	2,400,000	-
Jun 06, 2023	portnoy adam d.	bought	2,991,350	1.866	1,603,080	-
Jun 05, 2023	francis jennifer f.	acquired	-	-	20,000	president and ceo
Jun 05, 2023	portnoy adam d.	bought	4,065,450	1.7538	2,318,080	-
Jun 05, 2023	harrington john l.	acquired	-	-	20,000	-

Which funds bought or sold DHC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	226,856	471,356	-%
Apr 19, 2024	Sumitomo Mitsui Trust Holdings, Inc.	reduced	-2.55	-334,260	596,798	-%
Apr 19, 2024	State of Alaska, Department of Revenue	added	0.52	-142,000	277,000	-%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	added	99.45	8,949	37,638	-%
Apr 18, 2024	Oak Thistle LLC	sold off	-100	-53,291	-	-%
Apr 18, 2024	Verum Partners LLC	added	3.28	-13,659	28,932	0.01%
Apr 15, 2024	Sound Income Strategies, LLC	unchanged	-	-318	610	-%
Apr 12, 2024	HARBOR INVESTMENT ADVISORY, LLC	unchanged	-	-8,960	17,220	-%
Apr 08, 2024	Pensionfund Sabic	unchanged	-	-26,000	49,000	0.01%
Apr 05, 2024	GAMMA Investing LLC	reduced	-0.6	-1,138	6,556	-%

Are Funds Buying or Selling DHC?

Are funds buying DHC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own DHC

No. of Funds

Unveiling Diversified Healthcare Trust's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	silver point capital l.p.	6.5%	15,720,000	SC 13G
Feb 13, 2024	vanguard group inc	8.35%	20,078,770	SC 13G/A
Feb 09, 2024	charles schwab investment management inc	5.97%	14,346,995	SC 13G
Jan 26, 2024	millennium management llc	0.3%	834,008	SC 13G/A
Jan 26, 2024	blackrock inc.	7.8%	18,689,085	SC 13G/A
Dec 22, 2023	flat footed llc	9.8%	23,487,000	SC 13D/A
Oct 05, 2023	d. e. shaw & co, l.p.	5.7%	13,768,926	SC 13D/A
Sep 19, 2023	flat footed llc	9.8%	23,487,000	SC 13D/A
Jul 18, 2023	d. e. shaw & co, l.p.	5.8%	14,011,563	SC 13D/A
Jun 30, 2023	h/2 special opportunities iv l.p.	6.22%	12	SC 13D

Recent SEC filings of Diversified Healthcare Trust

View All Filings

Date Filed	Form Type	Document
Mar 26, 2024	DEFA14A	DEFA14A
Mar 26, 2024	DEF 14A	DEF 14A
Mar 26, 2024	ARS	ARS
Mar 01, 2024	POSASR	POSASR
Feb 26, 2024	8-K	Current Report
Feb 26, 2024	10-K	Annual Report
Feb 14, 2024	SC 13G	Major Ownership Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 09, 2024	SC 13G	Major Ownership Report
Jan 26, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to Diversified Healthcare Trust)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
AMT	81.2B	11.1B	-9.63%	-14.57%	59.43	7.29	4.04%	-19.43%
CCI	41.5B	7.0B	-7.14%	-23.31%	27.61	5.94	-0.07%	-10.36%
AVB	26.8B	2.8B	3.01%	9.02%	28.86	9.68	6.73%	-18.30%
ARE	19.9B	3.0B	-4.73%	-3.60%	103.23	6.73	10.44%	-74.28%
AMH	12.9B	1.6B	-1.98%	8.50%	29.83	8.02	7.80%	39.39%
REG	11.1B	1.3B	1.26%	0.15%	30.42	8.39	8.04%	-24.50%
BXP	9.9B	3.3B	-0.65%	20.81%	51.88	3.01	5.31%	-77.32%
MID-CAP
FRT	8.5B	1.1B	3.35%	7.17%	36.02	7.54	5.38%	-38.52%
MAC	3.5B	884.1M	-4.94%	65.24%	-12.72	3.94	2.90%	-314.82%
SLG	3.4B	899.4M	-0.98%	126.14%	-6.02	3.78	-0.45%	-623.11%
SMALL-CAP
AAT	1.3B	441.2M	2.71%	21.12%	20.35	2.98	4.38%	15.77%
AIV	1.2B	198.2M	0.88%	3.60%	-7.42	5.71	-43.33%	-270.70%
MFA	1.1B	605.6M	-6.60%	4.26%	13.7	1.81	25.53%	134.62%
NYMT	656.9M	258.7M	3.60%	-29.41%	-13.5	2.54	0.11%	83.70%
IVR	415.3M	277.9M	-9.02%	-18.46%	-26.19	1.49	44.33%	96.06%

Diversified Healthcare Trust News

Latest updates

Diversified Healthcare Trust Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	1.4%	361,535,000	356,524,000	346,219,000	346,030,000	336,885,000	322,920,000	313,028,000	310,733,000	336,731,000	337,416,000	346,341,000	362,724,000	384,909,000	394,339,000	410,311,000	442,467,000	256,039,000	255,827,000	262,003,000	266,286,000	285,222,000
Costs and Expenses	4.4%	394,125,000	377,454,000	379,248,000	362,771,000	355,062,000	355,971,000	332,143,000	334,214,000	352,980,000	346,753,000	353,717,000	360,912,000	375,721,000	454,104,000	409,314,000	405,744,000	280,392,000	243,646,000	206,100,000	213,288,000	251,361,000
Operating Expenses	1.7%	303,411,000	298,432,000	286,228,000	286,080,000	285,166,000	289,096,000	266,066,000	268,742,000	273,716,000	266,073,000	264,632,000	287,391,000	302,207,000	315,650,000	301,915,000	316,585,000	126,572,000	125,083,000	120,193,000	117,222,000	117,440,000
S&GA Expenses	-13.4%	6,020,000	6,954,000	7,284,000	5,873,000	5,764,000	6,179,000	7,207,000	7,285,000	8,549,000	8,870,000	9,126,000	7,542,000	7,461,000	6,988,000	7,312,000	8,832,000	8,741,000	9,604,000	8,867,000	9,816,000	657,000
EBITDA Margin	-0.4%	0.14	0.14	0.13	0.10	0.33	0.68	0.69	0.75	0.51	0.22	0.20	0.18	-	-	-	-	-	-	-	-	-
Interest Expenses	2.3%	48,853,000	47,758,000	47,384,000	47,780,000	49,341,000	46,936,000	55,975,000	57,131,000	63,518,000	64,493,000	67,657,000	60,091,000	57,768,000	58,091,000	43,974,000	41,650,000	43,272,000	44,817,000	46,412,000	45,611,000	45,506,000
Income Taxes	-65.1%	66,000	189,000	221,000	-31,000	-135,000	13,000	-640,000	1,472,000	406,000	595,000	191,000	238,000	202,000	365,000	1,126,000	-443,000	483,000	-146,000	-35,000	134,000	32,000
Earnings Before Taxes	-22.1%	-79,900,000	-65,445,000	-75,279,000	-52,042,000	-62,827,000	-83,606,000	-113,227,000	238,541,000	367,164,000	-87,409,000	-32,454,000	-65,945,000	-14,718,000	-105,423,000	-23,616,000	10,700,000	-49,920,000	-28,175,000	-35,981,000	31,234,000	-116,783,500
EBT Margin	-4.8%	-0.19	-0.18	-0.20	-0.24	-0.02	0.32	0.31	0.36	0.13	-0.14	-0.15	-0.14	-	-	-	-	-	-	-	-	-
Net Income	-55.9%	-102,564,000	-65,779,000	-72,571,000	-52,658,000	-65,322,000	-81,492,000	-109,383,000	240,423,000	364,135,500	-89,343,000	-32,645,000	-66,183,000	-17,597,000	-106,888,000	-24,742,000	11,143,000	-51,697,000	-29,390,000	-35,816,000	31,504,000	-118,543,000
Net Income Margin	-12.5%	-0.21	-0.18	-0.20	-0.23	-0.01	0.32	0.31	0.36	0.13	-0.14	-0.15	-0.14	-	-	-	-	-	-	-	-	-
Free Cashflow	48.6%	-7,209,000	-14,031,000	25,681,000	6,042,000	-3,405,000	-5,092,000	-24,592,000	-7,264,000	-50,125,000	-40,244,000	-7,776,000	34,822,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-1.5%	5,446	5,530	5,585	5,667	6,002	6,072	6,146	6,775	6,624	7,066	7,180	7,543	6,476	6,535	6,601	6,704	6,654	6,917	7,099	7,146	7,160
Cash Equivalents	-11.6%	246	278	338	380	658	691	705	732	635	795	849	843	91.00	82.00	78.00	70.00	52.00	49.00	48.00	40.00	70.00
Liabilities	0.7%	3,109	3,089	3,076	3,083	3,363	3,366	3,356	3,875	3,961	4,656	4,675	4,998	3,857	3,893	3,846	3,917	3,777	3,949	4,062	4,032	3,981
Shareholder's Equity	-4.3%	2,337	2,442	2,509	2,584	2,639	2,706	2,790	2,901	2,662	2,410	2,505	2,545	2,619	2,642	2,755	2,787	2,877	2,968	3,037	3,113	3,180
Retained Earnings	-5.5%	1,778	1,881	1,947	2,019	2,072	2,137	2,219	2,328	2,088	1,722	1,811	1,846	1,913	1,929	2,036	2,062	2,053	2,104	2,134	2,171	2,141
Additional Paid-In Capital	0.0%	4,618	4,618	4,618	4,617	4,617	4,617	4,616	4,616	4,615	4,615	4,615	4,614	4,614	4,614	4,613	4,613	4,613	4,612	4,612	4,612	4,611
Shares Outstanding	0.0%	240	240	240	240	240	238	238	238	238	238	238	238	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	111	115	119	123	128	132	136	141	145	148	153	157
Float	-	-	-	485	-	-	-	429	-	-	-	1,000	-	-	-	1,000	-	-	-	1,900	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	48.6%	-7,209	-14,031	25,681	6,042	-3,405	-5,092	-24,592	-7,264	-50,125	-40,244	-7,776	34,822	-435	48,306	54,361	56,312	70,175	69,796	84,359	41,515	106,818
Cashflow From Investing	15.2%	-51,265	-60,466	-33,636	-56,744	-96,005	-44,001	-60,639	588,353	265,581	-42,474	54,892	-35,303	1,700	-34,739	19,244	-26,641	112,405	75,400	-58,326	-43,308	-37,852
Cashflow From Financing	856.4%	26,330	-3,481	-17,631	-254,931	-13,093	-18,504	-538,363	-106,038	-9,948	-13,934	-309,032	1,079,637	-8,791	-8,960	-65,073	3,341	-193,805	-142,913	-19,619	-13,526	-154,887
Dividend Payments	-	2,403	-	-	2,397	2,397	-	-	2,390	2,390	-	-	2,383	2,382	-	-	-	-	-	-	-	-
Buy Backs	-98.0%	7.00	353	27.00	6.00	6.00	160	-	5.00	2.00	322	59.00	-	-	142	8.00	21.00	7.00	259	33.00	-	4.00

DHC Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Revenue	$ 1,410,308,000	$ 1,283,566,000	$ 1,383,212,000
Expenses:
Property operating expenses	1,174,151,000	1,109,070,000	1,091,812,000
Depreciation and amortization	284,083,000	239,280,000	271,131,000
General and administrative	26,131,000	26,435,000	34,087,000
Acquisition and certain other transaction related costs	10,853,000	2,605,000	17,506,000
Impairment of assets	18,380,000	0	(174,000)
Total expenses	1,513,598,000	1,377,390,000	1,414,362,000
Gain on sale of properties	1,205,000	321,862,000	492,272,000
Gains and losses on equity securities, net	8,126,000	(25,660,000)	(42,232,000)
Interest and other income	15,536,000	15,929,000	20,635,000
Interest expense (including net amortization of debt premiums, discounts and issuance costs of $11,811, $8,658 and $13,408, respectively)	(191,775,000)	(209,383,000)	(255,759,000)
Loss on modification or early extinguishment of debt	(2,468,000)	(30,043,000)	(2,410,000)
(Loss) income from continuing operations before income tax expense and equity in net (losses) earnings of investees	(272,666,000)	(21,119,000)	181,356,000
Income tax expense	(445,000)	(710,000)	(1,430,000)
Equity in net (losses) earnings of investees	(20,461,000)	6,055,000	0
Net (loss) income	(293,572,000)	(15,774,000)	179,926,000
Net income attributable to noncontrolling interest	0	0	(5,411,000)
Net (loss) income attributable to common shareholders	$ (293,572,000)	$ (15,774,000)	$ 174,515,000
Weighted average shares used in computing earnings per common share:
Weighted average common shares outstanding (basic) (in shares)	238,836	238,314	237,967
Weighted average common shares outstanding (diluted) (in shares)	238,836	238,314	237,967
Per common share amounts (basic and diluted)
Net income (loss) attributable to common shareholders - basic (in dollars per share)	$ (1.23)	$ (0.07)	$ 0.73
Net income (loss) attributable to common shareholders - diluted (in dollars per share)	$ (1.23)	$ (0.07)	$ 0.73
Affiliated Entity
Expenses:
Equity in net (losses) earnings of investees	$ (20,461,000)	$ 6,055,000	$ 0
Rental income
Revenues:
Revenue	258,400,000	260,740,000	408,589,000
Residents fees and services
Revenues:
Revenue	$ 1,151,908,000	$ 1,022,826,000	$ 974,623,000

DHC Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands

Dec. 31, 2023

Dec. 31, 2022

Real estate properties:

Land

$ 652,977

$ 668,918

Buildings and improvements

6,165,490

6,023,625

Total real estate properties, gross

6,818,467

6,692,543

Accumulated depreciation

(2,020,843)

(1,828,352)

Total real estate properties, net

4,797,624

4,864,191

Investments in unconsolidated joint ventures

129,916

155,477

Assets of properties held for sale

9,447

385

Cash and cash equivalents

245,939

658,065

Restricted cash

^[1]

1,022

30,237

Investments in equity securities

5,880

Acquired real estate leases and other intangible assets, net

33,948

45,351

Other assets, net

222,159

233,791

Total assets

5,446,136

6,002,093

LIABILITIES AND SHAREHOLDERS' EQUITY

Secured credit facility

700,000

Secured debt and finance leases, net

13,020

30,177

Liabilities of properties held for sale

Accrued interest

22,847

29,417

Other liabilities

262,456

280,986

Total liabilities

3,109,245

3,363,482

Commitments and contingencies

Shareholders' equity:

Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 240,423,898 and 239,694,842 shares issued and outstanding, respectively

2,405

2,397

Additional paid in capital

4,618,470

4,617,031

Cumulative net income

1,778,278

2,071,850

Cumulative distributions

(4,062,262)

(4,052,667)

Total equity attributable to common shareholders

2,336,891

2,638,611

Total liabilities and shareholders' equity

5,446,136

6,002,093

Secured Debt

Real estate properties:

Total real estate properties, net

1,112,243

58,503

LIABILITIES AND SHAREHOLDERS' EQUITY

Senior notes

731,211

Unsecured debt

LIABILITIES AND SHAREHOLDERS' EQUITY

Senior notes

2,072,618

2,317,700

Affiliated Entity

Real estate properties:

Due from affiliates

6,081

8,716

LIABILITIES AND SHAREHOLDERS' EQUITY

Due to affiliates

$ 7,061

$ 5,202

[1]

As of December 31, 2022 and 2021, restricted cash consisted of proceeds from the sale of assets and proceeds from the sale of joint venture interests held as collateral pursuant to the agreement governing our former credit facility, or our credit agreement. In December 2023, we repaid all $450,000 outstanding under such secured credit facility with Wells Fargo Bank, National Association, as administrative agent and a lender, and a syndicate of other lenders, and then terminated our credit agreement in accordance with its terms and without penalty. As such, we are no longer required to hold any proceeds from the sale of properties as restricted cash. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties.

About Diversified Healthcare Trust

DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of June 30, 2023, DHC's approximately $7.1 billion portfolio included 376 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 9 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with approximately $36 billion in assets under management as of June 30, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.

CEO	Ms. Jennifer F. Francis
WEBSITE	dhcreit.com
INDUSTRY	REIT Mortgage

Diversified Healthcare Trust Frequently Asked Questions

What is the ticker symbol for Diversified Healthcare Trust? What does DHC stand for in stocks?

DHC is the stock ticker symbol of Diversified Healthcare Trust. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Diversified Healthcare Trust (DHC)?

As of Tue Apr 23 2024, market cap of Diversified Healthcare Trust is 579.41 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DHC stock?

You can check DHC's fair value in chart for subscribers.

What is the fair value of DHC stock?

You can check DHC's fair value in chart for subscribers. The fair value of Diversified Healthcare Trust is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Diversified Healthcare Trust is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DHC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Diversified Healthcare Trust a good stock to buy?

The fair value guage provides a quick view whether DHC is over valued or under valued. Whether Diversified Healthcare Trust is cheap or expensive depends on the assumptions which impact Diversified Healthcare Trust's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DHC.

What is Diversified Healthcare Trust's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, DHC's PE ratio (Price to Earnings) is -1.97 and Price to Sales (PS) ratio is 0.41. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DHC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Diversified Healthcare Trust's stock?

In the past 10 years, Diversified Healthcare Trust has provided -0.156 (multiply by 100 for percentage) rate of return.